Priyanka Mahapatra

Stories

Landmark trial shows continuous glucose monitors cut A1c in type 2 diabetes patients not on insulin

Advocated for expanding CGM access to non-insulin patients at high cardiovascular risk

For millions of Americans with type 2 diabetes who don't take insulin, checking blood sugar has meant fingerstick tests a few times a day. A 26-week trial published in the New England Journal of Medicine shows that continuous glucose monitors (CGMs) — small sensors worn on the arm that stream glucose readings — kept patients in a healthy blood sugar range for about five extra hours each day.

Updated 1 hour ago